Φορτώνει......
The Acetylcholine-Activated Potassium Current Inhibitor XAF-1407 Terminates Persistent Atrial Fibrillation in Goats
Aims: The acetylcholine-activated inward rectifier potassium current (I(KACh)) has been proposed as an atrial-selective target for the treatment of atrial fibrillation (AF). Using a novel selective I(KACh) inhibitor XAF-1407, the study investigates the effect of I(KACh) inhibition in goats with paci...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Front Pharmacol |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Frontiers Media S.A.
2021
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7873360/ https://ncbi.nlm.nih.gov/pubmed/33584287 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.608410 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|